Apogee's $350M of­fer­ing; Bio­mX merges with Adap­tive Phage

Plus, news about Telios Phar­ma and Celldex Ther­a­peu­tics:

An­oth­er day, an­oth­er pub­lic of­fer­ing: Apogee Ther­a­peu­tics is aim­ing to raise $350 mil­lion in a stock sale …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER